1
|
Allergen challenge increases anandamide in bronchoalveolar fluid of patients with allergic asthma.
|
Clin Pharmacol Ther
|
2011
|
1.41
|
2
|
Lymphocytes in the bronchoalveolar space reenter the lung tissue by means of the alveolar epithelium, migrate to regional lymph nodes, and subsequently rejoin the systemic immune system.
|
Anat Rec
|
2001
|
1.18
|
3
|
Lung fibroblasts from patients with emphysema show markers of senescence in vitro.
|
Respir Res
|
2006
|
1.18
|
4
|
Measurement of intracellular cytokines.
|
Immunol Today
|
1996
|
1.12
|
5
|
Lymphocytes migrate from the blood into the bronchoalveolar lavage and lung parenchyma in the asthma model of the brown Norway rat.
|
Am J Respir Crit Care Med
|
2000
|
1.07
|
6
|
Ex vivo lung function measurements in precision-cut lung slices (PCLS) from chemical allergen-sensitized mice represent a suitable alternative to in vivo studies.
|
Toxicol Sci
|
2008
|
1.04
|
7
|
Ex vivo testing of immune responses in precision-cut lung slices.
|
Toxicol Appl Pharmacol
|
2008
|
1.03
|
8
|
A toxicological evaluation of inhaled solid lipid nanoparticles used as a potential drug delivery system for the lung.
|
Eur J Pharm Biopharm
|
2010
|
0.97
|
9
|
Surfactant protein levels in bronchoalveolar lavage after segmental allergen challenge in patients with asthma.
|
Allergy
|
2006
|
0.96
|
10
|
Dysfunction of pulmonary surfactant in asthmatics after segmental allergen challenge.
|
Am J Respir Crit Care Med
|
1999
|
0.92
|
11
|
[Health effects of particulate matter exposure: current scientific knowledge].
|
Pneumologie
|
2009
|
0.91
|
12
|
Pulmonary surfactant activity is impaired in lung transplant recipients.
|
Am J Respir Crit Care Med
|
1998
|
0.90
|
13
|
The neuropeptide calcitonin gene-related peptide affects allergic airway inflammation by modulating dendritic cell function.
|
Clin Exp Allergy
|
2011
|
0.90
|
14
|
Surfactant proteins SP-A and SP-D as modulators of the allergic inflammation in asthma.
|
Pathobiology
|
2003
|
0.89
|
15
|
Diagnostic value of outcome measures following allergen exposure in an environmental challenge chamber compared with natural conditions.
|
Clin Exp Allergy
|
2010
|
0.88
|
16
|
Pituitary adenylate cyclase-activating peptide receptor 1 mediates anti-inflammatory effects in allergic airway inflammation in mice.
|
Clin Exp Allergy
|
2010
|
0.87
|
17
|
[Fulminant course of leptospirosis complicated by multiple organ failure].
|
Z Gastroenterol
|
2001
|
0.86
|
18
|
Local release of eosinophil peroxidase following segmental allergen provocation in asthma.
|
Clin Exp Allergy
|
2003
|
0.85
|
19
|
Surfactant protein D inhibits early airway response in Aspergillus fumigatus-sensitized mice.
|
Clin Exp Allergy
|
2006
|
0.85
|
20
|
Increase of inactive intra-alveolar surfactant subtypes in lungs of asthmatic Brown Norway rats.
|
Virchows Arch
|
2002
|
0.84
|
21
|
Identification of eosinophils by flow cytometry.
|
Cytometry
|
1996
|
0.84
|
22
|
Exogenous surfactant improves survival and surfactant function in ischaemia-reperfusion injury in minipigs.
|
Eur Respir J
|
1999
|
0.82
|
23
|
Effect of anti-nerve growth factor on early and late airway responses in allergic rats.
|
Allergy
|
2003
|
0.82
|
24
|
Surfactant function affected by airway inflammation and cooling: possible impact on exercise-induced asthma.
|
Eur Respir J
|
2000
|
0.81
|
25
|
Effects of acute in vitro exposure of murine precision-cut lung slices to gaseous nitrogen dioxide and ozone in an air-liquid interface (ALI) culture.
|
Toxicol Lett
|
2010
|
0.81
|
26
|
Phospholipid molecular species of bronchoalveolar lavage fluid after local allergen challenge in asthma.
|
Am J Physiol Lung Cell Mol Physiol
|
2000
|
0.81
|
27
|
Comparison of non-invasive measures of cholinergic and allergic airway responsiveness in rats.
|
Acta Physiol (Oxf)
|
2006
|
0.80
|
28
|
Lymphocyte subsets in distinct lung compartments show a different ability to produce interferon-gamma (IFN-gamma) during a pulmonary immune response.
|
Clin Exp Immunol
|
1998
|
0.80
|
29
|
A combination of cetirizine and pseudoephedrine has therapeutic benefits when compared to single drug treatment in allergic rhinitis.
|
Int J Clin Pharmacol Ther
|
2009
|
0.78
|
30
|
Prevalence of malignancies after lung transplantation.
|
Transplant Proc
|
1998
|
0.76
|
31
|
FK506 rescue therapy in lung transplantation.
|
Transplant Proc
|
1998
|
0.75
|
32
|
Endobronchial allergen challenge.
|
Eur Respir J Suppl
|
1998
|
0.75
|
33
|
Determination of genotoxicity by the Comet assay applied to murine precision-cut lung slices.
|
Toxicol In Vitro
|
2012
|
0.75
|
34
|
[Recruitment of immunocompetent cells in a transplanted lung is not impaired despite incompletel reinnervation].
|
Pneumologie
|
2000
|
0.75
|
35
|
[Swollen parotid gland and lower leg erythema. Presentation of differential diagnosis and therapy based on a case report].
|
Fortschr Med
|
1997
|
0.75
|
36
|
Pulmonary uptake of bupivacaine in isolated perfused rat lung.
|
Naunyn Schmiedebergs Arch Pharmacol
|
1995
|
0.75
|
37
|
[Effects of particulate air pollution on human health. Statement of the German Society of Pneumology on the discussion about fine particulate air pollution].
|
Pneumologie
|
2005
|
0.75
|
38
|
[Guidelines of the American Thoracic Society/American Lung Association for education in pneumology and in pneumology and intensive care medicine. Accreditation Council for Graduate Medical Education (ACGME)].
|
Pneumologie
|
1996
|
0.75
|